Abstract
Lipids are the major substrate for cardiac ATP production and they are derived from adipose tissue or lipoprotein triglycerides. Lipoproteins are synthesized in the liver and they obtain their mature form following interaction with enzymes that are present in the circulation. Lipoprotein-derived fatty acids are released by lipoprotein lipase and are then taken up by cardiomyocytes either passively or via fatty acid receptors, such as CD36. Uptake of remnant lipoproteins via cardiomyocyte lipoprotein receptors is also possible. Besides fatty acids, other hydrophobic molecules such as cholesteryl esters, retinyl esters and vitamins are delivered by lipoproteins to the heart. While lipids are important for normal cardiac function, excessive lipid uptake, also known as lipotoxicity, may lead to cardiac abnormalities. This chapter focuses on the role of lipoproteins in providing fatty acids and other essential lipids to the heart in healthy conditions as well as in cardiac disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Taegtmeyer H, Mcnulty P, Young ME (2002) Adaptation and maladaptation of the heart in diabetes: Part I: general concepts. Circulation 105:1727–1733
Ballard FB, Danforth WH, Naegle S et al (1960) Myocardial metabolism of fatty acids. J Clin Invest 39:717–723
Hamilton JA (1998) Fatty acid transport: difficult or easy? J Lipid Res 39:467–481
Carley AN, Kleinfeld AM (2011) Fatty acid (FFA) transport in cardiomyocytes revealed by imaging unbound FFA is mediated by an FFA pump modulated by the CD36 protein. J Biol Chem 286:4589–4597
Coburn CT, Knapp FF Jr, Febbraio M et al (2000) Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout mice. J Biol Chem 275:32523–33259
Gimeno RE, Ortegon AM, Patel S et al (2003) Characterization of a heart-specific fatty acid transport protein. J Biol Chem 278:16039–16044
Kazantzis M, Stahl A (2012) Fatty acid transport proteins implications in physiology and disease. Biochim Biophys Acta 1821:852–857
Bharadwaj KG, Hiyama Y, Hu Y et al (2010) Chylomicron- and VLDL-derived lipids enter the heart through different pathways: in vivo evidence for receptor- and non-.receptor-mediated fatty acid uptake. J Biol Chem 285:37976–37986
Fielding CJ (1978) Metabolism of cholesterol-rich chylomicroms mechanism of binding and uptake of cholesteryl esters by the vascular bed of the perfused rat heart. J Clin Invest 62:141–151
Mardy K, Belke DD, Severson DL (2001) Chylomicron metabolism by the isolated perfused mouse heart. Am J Physiol Endocrinol Metab 281:E357–E364
Ginsberg HN, Fisher EA (2009) The ever-expanding role of degradation in the regulation of apolipoprotein B metabolism. J Lipid Res 50:S162–S166
Ota T, Gayet C, Ginsberg HN (2008) Inhibition of apolipoprotein B100 secretion by lipid-induced hepatic endoplasmic reticulum stress in rodents. J Clin Invest 118:316–332
Tsai J, Zhang R, Qiu W et al (2009) Inflammatory NF-kappaB activation promotes hepatic apolipoprotein B100 secretion: evidence for a link between hepatic inflammation and lipoprotein production. Am J Physiol Gastrointest Liver Physiol 296:G1287–G1298
Spady DK, Huettinger M, Bilheimer DW et al (1987) Role of receptor-independent low density lipoprotein transport in the maintenance of tissue cholesterol balance in the normal and WHHL rabbit. J Lipid Res 28:32–41
Dietschy JM, Siperstein MD (1967) Effect of cholesterol feeding and fasting on sterol synthesis in seventeen tissues of the rat. J Lipid Res 8:97–104
Sakai N, Vaisman BL, Koch CA et al (1997) Targeted disruption of the mouse lecithin: cholesterol acyltransferase (LCAT) gene generation of a new animal model for human LCAT deficiency. J Biol Chem 272:7506–7510
Lee JY, Timmins JM, Mulya A et al (2005) HDLs in apoA-I transgenic Abca1 knockout mice are remodeled normally in plasma but are hypercatabolized by the kidney. J Lipid Res 46:2233–2245
Timmins JM, Lee JY, Boudyguina E et al (2005) Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I. J Clin Invest 115:1333–1342
Thuren T (2000) Hepatic lipase and HDL metabolism. Curr Opin Lipidol 11:277–283
Jaye M, Krawiec J (2004) Endothelial lipase and HDL metabolism. Curr Opin Lipidol 15:183–189
Acton S, Rigotti A, Landschulz KT et al (1996) Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 271:518–520
Horowitz BS, Goldberg IJ, Merab J et al (1993) Increased plasma and renal clearance of an exchangeable pool of apolipoprotein A-I in subjects with low levels of high density lipoprotein cholesterol. J Clin Invest 91:1743–1752
Nielsen LB, Veniant M, Boren J et al (1998) Genes for apolipoprotein B and microsomal triglyceride transfer protein are expressed in the heart: evidence that the heart has the capacity to synthesize and secrete lipoproteins. Circulation 98:13–16
Bartels ED, Nielsen JM, Hellgren LI et al (2009) Cardiac expression of microsomal triglyceride transfer protein is increased in obesity and serves to attenuate cardiac triglyceride accumulation. PLoS One 4:e5300
Nielsen LB, Bartels ED, Bollano E (2002) Overexpression of apolipoprotein B in the heart impedes cardiac triglyceride accumulation and development of cardiac dysfunction in diabetic mice. J Biol Chem 277:27014–27020
Pitas RE, Innerarity TL, Mahley RW (1980) Cell surface receptor binding of phospholipid protein complexes containing different ratios of receptor-active and -inactive E apoprotein. J Biol Chem 255:5454–5460
Herz J, Willnow TE (1995) Lipoprotein and receptor interactions in vivo. Curr Opin Lipidol 6:97–103
Takahashi S, Suzuki J, Kohno M et al (1995) Enhancement of the binding of triglyceride-rich lipoproteins to the very low density lipoprotein receptor by apolipoprotein E and lipoprotein lipase. J Biol Chem 270:15747–15754
Li X, Kypreos K, Zanni EE et al (2003) Domains of apoE required for binding to apoE receptor 2 and to phospholipids: implications for the functions of apoE in the brain. Biochemistry 42:10406–10417
Chroni A, Nieland TJ, Kypreos KE et al (2005) SR-BI mediates cholesterol efflux via its interactions with lipid-bound ApoE structural mutations in SR-BI diminish cholesterol efflux. Biochemistry 44:13132–13143
Li X, Kan HY, Lavrentiadou S et al (2002) Reconstituted discoidal ApoE-phospholipid particles are ligands for the scavenger receptor BI The amino-terminal 1–165 domain of ApoE suffices for receptor binding. J Biol Chem 277:21149–21157
Krimbou L, Denis M, Haidar B et al (2004) Molecular interactions between apoE and ABCA1: impact on apoE lipidation. J Lipid Res 45:839–888
Wu AL, Windmueller HG (1979) Relative contributions by liver and intestine to individual plasma apolipoproteins in the rat. J Biol Chem 254:7316–7322
Newman TC, Dawson PA, Rudel LL et al (1985) Quantitation of apolipoprotein E mRNA in the liver and peripheral tissues of nonhuman primates. J Biol Chem 260:2452–2457
Weisgraber KH (1990) Apolipoprotein E distribution among human plasma lipoproteins: role of the cysteine-arginine interchange at residue 112. J Lipid Res 31:1503–1511
Takahashi S, Kawarabayasi Y, Nakai T et al (1992) Rabbit very low density lipoprotein receptor: a low density lipoprotein receptor-like protein with distinct ligand specificity. Proc Natl Acad Sci U S A 89:9252–9256
Cal R, Castellano J, Revuelta-Lopez E et al (2012) Low-density lipoprotein receptor-related protein 1 mediates hypoxia-induced very low density lipoprotein-cholesteryl ester uptake and accumulation in cardiomyocytes. Cardiovasc Res 94:469–479
Kounnas MZ, Haudenschild CC, Strickland DK et al (1994) Immunological localization of glycoprotein 330 low density lipoprotein receptor related protein and 39 kDa receptor associated protein in embryonic mouse tissues. In Vivo 8:343–351
Acton SL, Scherer PE, Lodish HF et al (1994) Expression cloning of SR-BI a CD36-related class B scavenger receptor. J Biol Chem 269:21003–21009
Jong MC, Hofker MH, Havekes LM (1999) Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1 ApoC2 and ApoC3. Arterioscler Thromb Vasc Biol 19:472–484
Jackson RL, Tajima S, Yamamura T et al (1986) Comparison of apolipoprotein C-II-deficient triacylglycerol-rich lipoproteins and trioleoylglycerol/phosphatidylcholine-stabilized particles as substrates for lipoprotein lipase. Biochim Biophys Acta 875:211–219
Ito Y, Azrolan N, O'connell A et al (1990) Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice. Science 249:790–793
Takahashi T, Hirano T, Okada K et al (2003) Apolipoprotein CIII deficiency prevents the development of hypertriglyceridemia in streptozotocin-induced diabetic mice. Metabolism 52:1354–1359
Duncan JG, Bharadwaj KG, Fong JL et al (2010) Rescue of cardiomyopathy in peroxisome proliferator-activated receptor-alpha transgenic mice by deletion of lipoprotein lipase identifies sources of cardiac lipids and peroxisome proliferator-activated receptor-alpha activators. Circulation 121:426–435
Ruby MA, Goldenson B, Orasanu G et al (2010) VLDL hydrolysis by LPL activates PPAR-alpha through generation of unbound fatty acids. J Lipid Res 51:2275–2281
O'brien KD, Ferguson M, Gordon D et al (1994) Lipoprotein lipase is produced by cardiac myocytes rather than interstitial cells in human myocardium. Arterioscler Thromb 14:1445–1451
Beigneux AP, Davies BS, Gin P et al (2007) Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons. Cell Metab 5:279–291
Davies BS, Beigneux AP, Barnes RH 2nd et al (2010) GPIHBP1 is responsible for the entry of lipoprotein lipase into capillaries. Cell Metab 12:42–52
Levak-Frank S, Hofmann W, Weinstock PH et al (1999) Induced mutant mouse lines that express lipoprotein lipase in cardiac muscle but not in skeletal muscle and adipose tissue have normal plasma triglyceride and high-density lipoprotein-cholesterol levels. Proc Natl Acad Sci U S A 96:3165–3170
Augustus A, Yagyu H, Haemmerle G et al (2004) Cardiac-specific knock-out of lipoprotein lipase alters plasma lipoprotein triglyceride metabolism and cardiac gene expression. J Biol Chem 279:25050–25057
Davies BS, Goulbourne CN, Barnes RH 2nd et al (2012) Assessing mechanisms of GPIHBP1 and lipoprotein lipase movement across endothelial cells. J Lipid Res 53:2690–2697
Klinger MM, Margolis RU, Margolis RK (1985) Isolation and characterization of the heparan sulfate proteoglycans of brain use of affinity chromatography on lipoprotein lipase-agarose. J Biol Chem 260:4082–9040
Lookene A, Savonen R, Olivecrona G (1997) Interaction of lipoproteins with heparan sulfate proteoglycans and with lipoprotein lipase Studies by surface plasmon resonance technique. Biochemistry 36:5267–5275
Kinnunen PK, Jackson RL, Smith LC et al (1977) Activation of lipoprotein lipase by native and synthetic fragments of human plasma apolipoprotein C-II. Proc Natl Acad Sci U S A 74:4848–4851
Pennacchio LA, Olivier M, Hubacek JA et al (2001) An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science 294:169–173
Grosskopf I, Baroukh N, Lee SJ et al (2005) Apolipoprotein A-V deficiency results in marked hypertriglyceridemia attributable to decreased lipolysis of triglyceride-rich lipoproteins and removal of their remnants. Arterioscler Thromb Vasc Biol 25:2573–2579
Ginsberg HN, Le NA, Goldberg IJ et al (1986) Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo. J Clin Invest 78:1287–1295
Yao Z, Wang Y (2012) Apolipoprotein C-III and hepatic triglyceride-rich lipoprotein production. Curr Opin Lipidol 23:206–212
Julve J, Escola-Gil JC, Rotllan N et al (2010) Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome. Arterioscler Thromb Vasc Biol 30:232–238
Shimizugawa T, Ono M, Shimamura M et al (2002) ANGPTL3 decreases very low density lipoprotein triglyceride clearance by inhibition of lipoprotein lipase. J Biol Chem 277:33742–33748
Yoshida K, Shimizugawa T, Ono M et al (2002) Angiopoietin-like protein 4 is a potent hyperlipidemia-inducing factor in mice and inhibitor of lipoprotein lipase. J Lipid Res 43:1770–1772
Quagliarini F, Wang Y, Kozlitina J et al (2012) Atypical angiopoietin-like protein that regulates ANGPTL3. Proc Natl Acad Sci U S A 109:19751–19756
Sukonina V, Lookene A, Olivecrona T et al (2006) Angiopoietin-like protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activity in adipose tissue. Proc Natl Acad Sci U S A 103:17450–17455
Olivecrona G, Olivecrona T (2010) Triglyceride lipases and atherosclerosis. Curr Opin Lipidol 21:409–415
Chatterjee C, Sparks DL (2011) Hepatic lipase high density lipoproteins and hypertriglyceridemia. Am J Pathol 178:1429–1433
Jaye M, Lynch KJ, Krawiec J et al (1999) A novel endothelial-derived lipase that modulates HDL metabolism. Nat Genet 21:424–428
Nakajima H, Ishida T, Satomi-Kobayashi S et al (2013) Endothelial lipase modulates pressure overload-induced heart failure through alternative pathway for fatty acid uptake. Hypertension 61:1002–1007
Albers JJ, Vuletic S, Cheung MC (2012) Role of plasma phospholipid transfer protein in lipid and lipoprotein metabolism. Biochim Biophys Acta 1821:345–357
Yazdanyar A, Jiang XC (2012) Liver phospholipid transfer protein (PLTP) expression with a PLTP-null background promotes very low-density lipoprotein production in mice. Hepatology 56:576–584
Charles MA, Kane JP (2012) New molecular insights into CETP structure and function: a review. J Lipid Res 53:1451–1458
Iwai-Kanai E, Hasegawa K, Sawamura T et al (2001) Activation of lectin-like oxidized low-density lipoprotein receptor-1 induces apoptosis in cultured neonatal rat cardiac myocytes. Circulation 104:2948–2954
Baker DP, Van Lenten BJ, Fogelman AM et al (1984) LDL scavenger and beta-VLDL receptors on aortic endothelial cells. Arteriosclerosis 4:248–255
Goudriaan J, Espirito Santo SM, Voshol PJ et al (2004) The VLDL receptor plays a major role in chylomicron metabolism by enhancing LPL-mediated triglyceride hydrolysis. J Lipid Res 45:1475–1481
Perman JC, Bostrom P, Lindbom M et al (2011) The VLDL receptor promotes lipotoxicity and increases mortality in mice following an acute myocardial infarction. J Clin Invest 121:2625–2640
Masuzaki H, Jingami H, Matsuoka N et al (1996) Regulation of very-low-density lipoprotein receptor in hypertrophic rat heart. Circ Res 78:8–14
Wyne KL, Pathak K, Seabra MC et al (1996) Expression of the VLDL receptor in endothelial cells. Arterioscler Thromb Vasc Biol 16:407–415
Obunike JC, Lutz EP, Li Z et al (2001) Transcytosis of lipoprotein lipase across cultured endothelial cells requires both heparan sulfate proteoglycans and the very low density lipoprotein receptor. J Biol Chem 276:8934–8941
Yagyu H, Lutz EP, Kako Y et al (2002) Very low density lipoprotein (VLDL) receptor-deficient mice have reduced lipoprotein lipase activity. Possible causes of hypertriglyceridemia and reduced body mass with VLDL receptor deficiency. J Biol Chem 277:10037–10043
Willnow TE, Sheng Z, Ishibashi S et al (1994) Inhibition of hepatic chylomicron remnant uptake by gene transfer of a receptor antagonist. Science 264:1471–1474
Beisiegel U, Weber W, Ihrke G et al (1989) The LDL-receptor-related protein LRP is an apolipoprotein E-binding protein. Nature 341:162–164
Herz J, Qiu SQ, Oesterle A et al (1995) Initial hepatic removal of chylomicron remnants is unaffected but endocytosis is delayed in mice lacking the low density lipoprotein receptor. Proc Natl Acad Sci U S A 92:4611–4615
Cal R, Juan-Babot O, Brossa V et al (2012) Low density lipoprotein receptor-related protein 1 expression correlates with cholesteryl ester accumulation in the myocardium of ischemic cardiomyopathy patients. J Transl Med 10:160
Theilmeier G, Schmidt C, Herrmann J et al (2006) High-density lipoproteins and their constituent sphingosine-1-phosphate directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor. Circulation 114:1403–1409
Karliner JS (2013) Sphingosine kinase and sphingosine 1-phosphate in the heart: a decade of progress. Biochim Biophys Acta 1831:203–212
Reboulleau A, Robert V, Vedie B et al (2012) Involvement of cholesterol efflux pathway in the control of cardiomyocytes cholesterol homeostasis. J Mol Cell Cardiol 53:196–205
Traber MG, Diamond SR, Lane JC et al (1994) beta-Carotene transport in human lipoproteins. Comparisons with a-tocopherol. Lipids 29:665–669
Skrede B, Blomhoff HK, Smeland EB et al (1991) Retinyl esters in chylomicron remnants inhibit growth of myeloid and lymphoid leukaemic cells. Eur J Clin Invest 21:574–549
Haddad JG, Jennings AS, Aw TC (1988) Vitamin D uptake and metabolism by perfused rat liver: influences of carrier proteins. Endocrinology 123:498–504
Behrens WA, Thompson JN, Madere R (1982) Distribution of alpha-tocopherol in human plasma lipoproteins. Am J Clin Nutr 35:691–696
Lamon-Fava S, Sadowski JA, Davidson KW et al (1998) Plasma lipoproteins as carriers of phylloquinone (vitamin K1) in humans. Am J Clin Nutr 67:1226–1231
Lemieux S, Fontani R, Uffelman KD et al (1998) Apolipoprotein B-48 and retinyl palmitate are not equivalent markers of postprandial intestinal lipoproteins. J Lipid Res 39:1964–1971
Orth M, Hanisch M, Kroning G et al (1998) Fluorometric determination of total retinyl esters in triglyceride-rich lipoproteins. Clin Chem 44:1459–1465
Blaner WS, Obunike JC, Kurlandsky SB et al (1994) Lipoprotein lipase hydrolysis of retinyl ester. Possible implications for retinoid uptake by cells. J Biol Chem 269:16559–16565
Van Bennekum AM, Kako Y, Weinstock PH et al (1999) Lipoprotein lipase expression level influences tissue clearance of chylomicron retinyl ester. J Lipid Res 40:565–574
Madrazo JA, Kelly DP (2008) The PPAR trio: regulators of myocardial energy metabolism in health and disease. J Mol Cell Cardiol 44:968–975
Shneyvays V, Leshem D, Shmist Y et al (2005) Effects of menadione and its derivative on cultured cardiomyocytes with mitochondrial disorders. J Mol Cell Cardiol 39:149–158
Qin F, Rounds NK, Mao W et al (2001) Antioxidant vitamins prevent cardiomyocyte apoptosis produced by norepinephrine infusion in ferrets. Cardiovasc Res 51:736–748
Guan Z, Lui CY, Morkin E et al (2004) Oxidative stress and apoptosis in cardiomyocyte induced by high-dose alcohol. J Cardiovasc Pharmacol 44:696–702
Shirpoor A, Salami S, Khadem-Ansari MH et al (2009) Cardioprotective effect of vitamin E: rescues of diabetes-induced cardiac malfunction oxidative stress and apoptosis in rat. J Diabetes Complications 23:310–316
Toraason M, Wey H, Woolery M et al (1995) Arachidonic acid supplementation enhances hydrogen peroxide induced oxidative injury of neonatal rat cardiac myocytes. Cardiovasc Res 29:624–628
Qin F, Shite J, Liang CS (2003) Antioxidants attenuate myocyte apoptosis and improve cardiac function in CHF: association with changes in MAPK pathways. Am J Physiol Heart Circ Physiol 285:H822–H832
Zhao X, Feng T, Chen H et al (2008) Arsenic trioxide-induced apoptosis in H9c2 cardiomyocytes: implications in cardiotoxicity. Basic Clin Pharmacol Toxicol 102:419–425
Davis WL, Matthews JL, Goodman DB (1989) Glyoxylate cycle in the rat liver: effect of vitamin D3 treatment. FASEB J 3:1651–1655
Davis WL, Jones RG, Farmer GR et al (1989) The glyoxylate cycle in rat epiphyseal cartilage: the effect of vitamin-D3 on the activity of the enzymes isocitrate lyase and malate synthase. Bone 10:201–206
Lopaschuk GD, Ussher JR, Folmes CD et al (2010) Myocardial fatty acid metabolism in health and disease. Physiol Rev 90:207–258
Heather LC, Howell NJ, Emmanuel Y et al (2011) Changes in cardiac substrate transporters and metabolic proteins mirror the metabolic shift in patients with aortic stenosis. PLoS One 6:e26326
Steinbusch LK, Luiken JJ, Vlasblom R et al (2011) Absence of fatty acid transporter CD36 protects against Western-type diet-related cardiac dysfunction following pressure overload in mice. Am J Physiol Endocrinol Metab 301:E618–E627
Barger PM, Brandt JM, Leone TC et al (2000) Deactivation of peroxisome proliferator-activated receptor-alpha during cardiac hypertrophic growth. J Clin Invest 105:1723–1730
Yamamoto T, Takahashi S, Sakai J et al (1993) The very low density lipoprotein receptor A second lipoprotein receptor that may mediate uptake of fatty acids into muscle and fat cells. Trends Cardiovasc Med 3:144–148
Cominacini L, Pasini AF, Garbin U et al (2000) Oxidized low density lipoprotein (ox-LDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation of NF-kappaB through an increased production of intracellular reactive oxygen species. J Biol Chem 275:12633–12638
Zorn-Pauly K, Schaffer P, Pelzmann B et al (2005) Oxidized LDL induces ventricular myocyte damage and abnormal electrical activity—role of lipid hydroperoxides. Cardiovasc Res 66:74–83
Chandrakala AN, Sukul D, Selvarajan K et al (2012) Induction of brain natriuretic peptide and monocyte chemotactic protein-1 gene expression by oxidized low-density lipoprotein: relevance to ischemic heart failure. Am J Physiol Cell Physiol 302:C165–C177
Kang BY, Khan JA, Ryu S et al (2010) Curcumin reduces angiotensin II-mediated cardiomyocyte growth via LOX-1 inhibition. J Cardiovasc Pharmacol 55:417–424
Kang BY, Mehta JL (2009) Rosuvastatin attenuates Ang II-mediated cardiomyocyte hypertrophy via inhibition of LOX-1. J Cardiovasc Pharmacol Ther 14:283–291
Crass MF 3rd, Pieper GM (1975) Lipid and glycogen metabolism in the hypoxic heart: effects of epinephrine. Am J Physiol 229:885–889
Bilheimer DW, Buja LM, Parkey RW et al (1978) Fatty acid accumulation and abnormal lipid deposition in peripheral and border zones of experimental myocardial infarcts. J Nucl Med 19:276–283
Sundelin JP, Lidberg U, Nik AM et al (2013) Hypoxia-induced regulation of the very low density lipoprotein receptor. Biochem Biophys Res Commun 437:274–279
Heather LC, Pates KM, Atherton HJ et al (2013) Differential translocation of the fatty acid transporter FAT/CD36 and the glucose transporter GLUT4 coordinates changes in cardiac substrate metabolism during ischemia and reperfusion. Circ Heart Fail 6:1058–1066
Li D, Williams V, Liu L et al (2003) Expression of lectin-like oxidized low-density lipoprotein receptors during ischemia-reperfusion and its role in determination of apoptosis and left ventricular dysfunction. J Am Coll Cardiol 41:1048–1055
Kataoka K, Hasegawa K, Sawamura T et al (2003) LOX-1 pathway affects the extent of myocardial ischemia-reperfusion injury. Biochem Biophys Res Commun 300:656–660
Lu J, Wang X, Wang W et al (2012) LOX-1 abrogation reduces cardiac hypertrophy and collagen accumulation following chronic ischemia in the mouse. Gene Ther 19:522–531
Tao R, Hoover HE, Honbo N et al (2010) High-density lipoprotein determines adult mouse cardiomyocyte fate after hypoxia-reoxygenation through lipoprotein-associated sphingosine 1-phosphate. Am J Physiol Heart Circ Physiol 298:H1022–H1028
Frias MA, Lang U, Gerber-Wicht C et al (2010) Native and reconstituted HDL protect cardiomyocytes from doxorubicin-induced apoptosis. Cardiovasc Res 85:118–126
Morel S, Frias MA, Rosker C et al (2012) The natural cardioprotective particle HDL modulates connexin43 gap junction channels. Cardiovasc Res 93:41–49
Frias MA, James RW, Gerber-Wicht C et al (2009) Native and reconstituted HDL activate Stat3 in ventricular cardiomyocytes via ERK1/2: role of sphingosine-1-phosphate. Cardiovasc Res 82:313–323
Somers SJ, Frias M, Lacerda L et al (2012) Interplay between SAFE and RISK pathways in sphingosine-1-phosphate-induced cardioprotection. Cardiovasc Drugs Ther 26:227–237
Chokshi A, Drosatos K, Cheema FH et al (2012) Ventricular assist device implantation corrects myocardial lipotoxicity reverses insulin resistance and normalizes cardiac metabolism in patients with advanced heart failure. Circulation 125:2844–2853
Boudina S, Abel ED (2007) Diabetic cardiomyopathy revisited. Circulation 115:3213–3223
Wende AR, Abel ED (2010) Lipotoxicity in the heart. Biochim Biophys Acta 1801:311–319
Niu YG, Evans RD (2008) Metabolism of very-low-density lipoprotein and chylomicrons by streptozotocin-induced diabetic rat heart: effects of diabetes and lipoprotein preference. Am J Physiol Endocrinol Metab 295:E1106–E1116
Sambandam N, Abrahani MA, Craig S et al (2000) Metabolism of VLDL is increased in streptozotocin-induced diabetic rat hearts. Am J Physiol Heart Circ Physiol 278:H1874–H1882
Kim MS, Wang F, Puthanveetil P et al (2008) Protein kinase D is a key regulator of cardiomyocyte lipoprotein lipase secretion after diabetes. Circ Res 103:252–260
Rodrigues B, Cam MC, Jian K et al (1997) Differential effects of streptozotocin-induced diabetes on cardiac lipoprotein lipase activity. Diabetes 46:1346–1353
Angin Y, Steinbusch LK, Simons PJ et al (2012) CD36 inhibition prevents lipid accumulation and contractile dysfunction in rat cardiomyocytes. Biochem J 448:43–53
Carley AN, Atkinson LL, Bonen A et al (2007) Mechanisms responsible for enhanced fatty acid utilization by perfused hearts from type 2 diabetic db/db mice. Arch Physiol Biochem 113:65–75
Iwasaki T, Takahashi S, Takahashi M et al (2005) Deficiency of the very low-density lipoprotein (VLDL) receptors in streptozotocin-induced diabetic rats: insulin dependency of the VLDL receptor. Endocrinology 146:3286–3294
Van De Weijer T, Schrauwen-Hinderling VB, Schrauwen P (2011) Lipotoxicity in type 2 diabetic cardiomyopathy. Cardiovasc Res 92:10–18
Drosatos K, Khan RS, Trent CM et al (2013) Peroxisome proliferator-activated receptor-gamma activation prevents sepsis-related cardiac dysfunction and mortality in mice. Circ Heart Fail 6:550–562
Gouni I, Oka K, Etienne J et al (1993) Endotoxin-induced hypertriglyceridemia is mediated by suppression of lipoprotein lipase at a post-transcriptional level. J Lipid Res 34:139–146
Kaufmann RL, Matson CF, Beisel WR (1976) Hypertriglyceridemia produced by endotoxin: role of impaired triglyceride disposal mechanisms. J Infect Dis 133:548–555
Nogueira AC, Kawabata V, Biselli P et al (2008) Changes in plasma free fatty acid levels in septic patients are associated with cardiac damage and reduction in heart rate variability. Shock 29:342–348
Schilling J, Lai L, Sambandam N et al (2011) Toll-like receptor-mediated inflammatory signaling reprograms cardiac energy metabolism by repressing peroxisome proliferator-activated receptor {gamma} coactivator-1 signaling. Circ Heart Fail 4:474–482
Drosatos K, Drosatos-Tampakaki Z, Khan R et al (2011) Inhibition of C-JUN-N-terminal kinase increases cardiac PPAR{alpha} expression and fatty acid oxidation and prevents LPS-induced heart dysfunction. J Biol Chem 286:36331–36339
Bagby GJ, Spitzer JA (1980) Lipoprotein lipase activity in rat heart and adipose tissue during endotoxic shock. Am J Physiol 238:H325–H330
Scholl RA, Lang CH, Bagby GJ (1984) Hypertriglyceridemia and its relation to tissue lipoprotein lipase activity in endotoxemic Escherichia coli bacteremic and polymicrobial septic rats. J Surg Res 37:394–401
Bagby GJ, Corll CB, Martinez RR (1987) Triacylglycerol kinetics in endotoxic rats with suppressed lipoprotein lipase activity. Am J Physiol 253:E59–E64
Feingold K, Kim MS, Shigenaga J et al (2004) Altered expression of nuclear hormone receptors and coactivators in mouse heart during the acute-phase response. Am J Physiol Endocrinol Metab 286:E201–E207
Lu B, Moser A, Shigenaga JK et al (2010) The acute phase response stimulates the expression of angiopoietin like protein 4. Biochem Biophys Res Commun 391:1737–1741
Jia L, Takahashi M, Morimoto H et al (2006) Changes in cardiac lipid metabolism during sepsis: the essential role of very low-density lipoprotein receptors. Cardiovasc Res 69:545–555
Read TE, Harris HW, Grunfeld C et al (1993) The protective effect of serum lipoproteins against bacterial lipopolysaccharide. Eur Heart J 14 (Suppl K):125–129
Ghoshal S, Witta J, Zhong J et al (2009) Chylomicrons promote intestinal absorption of lipopolysaccharides. J Lipid Res 50:90–97
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Drosatos, K., Goldberg, I.J. (2014). Lipoproteins: A Source of Cardiac Lipids. In: Lopaschuk, G., Dhalla, N. (eds) Cardiac Energy Metabolism in Health and Disease. Advances in Biochemistry in Health and Disease, vol 11. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1227-8_2
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1227-8_2
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-1226-1
Online ISBN: 978-1-4939-1227-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)